Slide 13
Slide 13 text
NormalizaDon
• Without Spike-ins or UMIs
– Between-sample normalizaDon methods
• Global scaling factors mostly developed for bulk RNA-Seq
• Number of zeros (see Lun et al., 2016. Genome Biology)
• With Spike-ins or UMIs
– Spike-ins: theoreDcally a good idea, but many challenges sDll
remain for scRNA-Seq (see Stegle et al., 2015, Tung et al., 2016);
ConflicDng view points on if ERCCs are appropriate
– UMIs: Reduces amplificaDon bias, not appropriate for isoform
or allele-specific expression
• Biological (nuisance?) variability
– differences among cells in cell-cycle stage or cell size
13